Washburn Therapeutics, Inc.

Basic Information

6743 Wilkins Ave.
Pittsburgh, PA, -


Company Profile


Additional Details

Field Value
DUNS: 803136758
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2

  1. Reduction of Burn Progression and Scar Contracture with Cytokine-Neutralizing Gels

    Amount: $150,000.00

    Washburn Therapeutics Inc. is developing biologically active gels that control inflammation by selectively neutralizing pro-inflammatory cytokines based on a technology being licensed exclusively by t ...

    SBIR Phase I 2013 Department of Defense Defense Health Program
  2. Development of Cytokine-Inhibiting Gels for Treating Chronic Wounds

    Amount: $185,770.00

    DESCRIPTION (provided by applicant): Chronic wounds developed by patients with diabetes are becoming an increasing burden for Americans and our health care system. Diabetic foot ulcers cost tens of th ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government